DOCSLIB.ORG

March 17, 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
March 17, 2021 1996 - 2021 SILVER JUBILEE YEAR TMQ to Marquez expand speeds up return operations ahead of Qatar in Qatar double-header Business | 01 Sport | 12 WEDNESDAY 17 MARCH 2021 4 SHA'ABAN - 1442 VOLUME 26 NUMBER 8564 www.thepeninsula.qa 2 RIYALS QFFD signs $10m contribution Amir visits Milipol Qatar 2021 agreement to support WHO QNA — DOHA that one billion more people benefiting from UHC, one The State of Qatar, repre- billion more people sup- sented by Qatar Fund for ported during emergencies Development (QFFD), and the and one billion more World Health Organization enjoying better health and (WHO) have signed a Core well-being. It also supports Contribution Agreement for the initiatives of speeding $10m to support WHO’s Thir- Core Contribution Agreement is up the access to the teenth General Programme of to support WHO’s Thirteenth essential supplies needed in Work (GPW 13) and for General Programme of Work the fight against COVID-19, COVID-19 response through (GPW 13) and for COVID-19 to include accelerating the the Access to COVID-19 Tools development of COVID-19 Accelerator (ACT-A). response through the Access to tests, treatment and vacci- This is the first Core Con- COVID-19 Tools Accelerator nation while ensuring fair tribution Agreement signed (ACT-A). access.” between the State of Qatar Dr. Hanan Al Kuwari com- and WHO, highlighting the The State of Qatar through mended the pivotal role of strong partnership and com- WHO, especially in the current mitment to work jointly Qatar Fund for Development difficult time as the world is ensuring the most vulnerable (QFFD) is providing its first fighting the coronavirus communities around the flexible funding to WHO in (COVID-19) pandemic. She world receive immediate and also affirms Qatar’s keenness support of the efforts done by Amir H H Sheikh Tamim bin Hamad Al Thani visited yesterday the 13th edition of international unhampered assistance to enhance its partnership with the agency to combat the exhibition for homeland security and civil defense (Milipol Qatar 2021) at the Doha Exhibition and when it is most needed. the WHO. She also praised the Minister of Public Health pandemic. outstanding role of Qatar Fund Convention Center. His Highness was briefed on the pavilions and sections of the exhibition as well H E Dr. Hanan Mohamed Al for Development in supporting as the latest innovations and technologies exhibited by local and international companies in the Kuwari said: “Contribution to Thirteenth General Pro- global effort to alleviate human fields of security, safety, cybersecurity and civil defense devices and equipment, and major event the WHO affirms Qatar’s ful- gramme of Work (GPW 13) suffering and support health, security management, in addition to a number of modern military armoured vehicles, weapons and fillment of its obligations and 2019-2023, to attain the education, and economic armoured cars. H H the Amir was accompanied by Prime Minister and Minister of Interior H E Sheikh keenness to support WHO’s “triple billion” target to ensure empowerment. `P4 Khalid bin Khalifa bin Abdulaziz Al Thani and a number of senior officials. Over 510,000 shots administered PM holds phone call with Saudi since start of COVID-19 National Minister of Interior Vaccination Program QNA — DOHA QNA — DOHA Prime Minister and Minister of 14,000 Interior H E Sheikh Khalid bin The Ministry of Public Health (MOPH) Khalifa bin Abdulaziz Al Thani has announced that 510,000 COVID-19 held yesterday a telephone call vaccine doses have been administered with HRH Minister of Interior since the start of the COVID-19 in the Kingdom of Saudi National Vaccination Program. Arabia, Prince Abdulaziz bin The Ministry stated that the Saud bin Nayef bin Abdulaziz recent availability of greater quan- Al Saud. tities of both the Moderna and Pfizer At the beginning of the call, and BioNTech vaccines has helped Every day around 14,000 of most the Prime Minister conveyed increase the pace of the vaccination vulnerable members of society the greetings of Amir H H program, with over 100,000 doses and essential workers are getting Sheikh Tamim bin Hamad Al being administered each week, vaccinated and becoming Thani to the Custodian of the meaning that every day around protected against COVID-19. Two Holy Mosques King 14,000 of most vulnerable members Salman bin Abdulaziz Al Saud Prime Minister meets Turkish official of society and essential workers are of the Kingdom of Saudi getting vaccinated and becoming to know that more than six out of every Arabia, and HRH the Crown Prime Minister and Minister of Interior H E Sheikh Khalid bin Khalifa bin Abdulaziz Al Thani protected against COVID-19. ten people aged 60 and above have Prince, Deputy Prime Minister, with Director of General Directorate of Security of the Republic of Turkey, H E Mehmet Aktas, The Ministry said that as it con- now received at least their first dose and Minister of Defense, Prince who is in Doha to participate in the 13th edition of international exhibition for homeland tinues to highlight the importance of of the vaccine, with 67 percent of Mohammed bin Salman bin security and civil defense (Milipol Qatar 2021). The meeting reviewed cooperation vaccination for the elderly, the number people over 70 years of age, and 63 Abdulaziz Al Saud, wishing relations and aspects of developing them, especially in the security fields, in addition of older people receiving the vaccine percent of people over 60 years of age them good health and the to reviewing a number of issues of common concern. is constantly rising. It is very reassuring having received the vaccine. `P5 Saudi people progress and development. For his part, HRH the Saudi Agreement signed Minister of Interior conveyed Strong Qatari participation at Milipol expo the greetings of the Custodian to establish UNDP of the Two Holy Mosques and SIDI MOHAMED traffic systems project on tablet in the exhibition, Lieutenant He also stated that the the Saudi Crown Prince to H H office in Doha THE PENINSULA devices, and project of coastal Colonel Dr. Eng. Ali Al Rashed, device is 100 percent Qatari- the Amir, wishing His Highness and border security services on Commander of Security Tech- owned and manufactured, and success , and the Qatari people QNA — DOHA Milipol Qatar 2021 exhibition tablet devices. nologies in Lekhwiya, said that being used at Hamad Interna- further progress and pros- which is set to conclude today Among the distinguished the technical solution provided tional Airport and has suc- perity. The call dealt with The State of Qatar and the saw a distinguished partici- pavilions in the exhibition is by the invention is to detect the ceeded in detecting a number reviewing fraternal relations United Nations Development pation from Qatari entities and also Internal Security Force suspicious people and narcotics of cases. between the two countries and Program (UNDP) have signed private companies with (Lekhwiya) pavilion, which takers. “The pavilion also the means to enhance them, an agreement to establish an presence of over 70 local exhib- includes the latest devices and Lieutenant Colonel Al includes many devices particularly in the security office for the program in the itors. technologies that it uses, Rashed added: “If a person developed by Lekhwiya in field. Additionally, it discussed State of Qatar. The Ministry of Interior is including Smart Security Inves- stands in front of the device for cooperation with strategic a number of topics of joint Permanent Representative participating in the exhibition tigator device. scanning his eyes and temper- partners, such as a moving interest. of Qatar to the United Nations with a large pavilion comprising Speaking to The Peninsula ature, the device notifies if the detection vehicle that deter- in New York H E Ambassador several departments, where on the sidelines of the event person is criminal, drugs taker mines load on vehicles. It is Sheikha Alya Ahmed bin Saif Al- each of them are offering about Lekhwiya's participation or carries infectious disease.” also equipped with an auto- Thani signed the agreement on models of modern equipment matic analysis system to behalf of the State of Qatar, while acquired by some departments The Ministry of Interior is participating determine the type of pro- UNDP Administrator Achim while others offering models of hibited substance loaded on Steiner signed the agreement on services provided to the public in the exhibition with a large pavilion the vehicle,” he said. the UNDP’s behalf. and employed in awareness comprising several departments, For his part, CEO and The agreement to establish efforts. where each of them are offering Founder of Ideal Solutions, ROUND OF 16 the Doha-based office comes The Information Systems models of modern equipment Mahmoud Amer, affirmed that TODAY 11PM QATAR TIME within the framework of Directorate of the Ministry of acquired by some departments while the State of Qatar has become FC Bayern Munich vs increasing the effectiveness of gov- Interior is exhibiting, through at the forefront of countries that ernment-funded development its pavilion, five major projects, others offering models of services have been able to develop and SS Lazio (4-1) programs and strengthening coop- including maritime registration provided to the public and employed adopt information and commu- Chelsea vs Atlético eration programs in areas of service, project of security bag, in awareness efforts. nication technology in all vital Madrid (1-0) common interest. `P4 security clearance project, areas. `P4 02 HOME WEDNESDAY 17 MARCH 2021 Amir meets Iraq Amir visits Milipol Qatar 2021 exhibition Foreign Minister QNA — DOHA Amir H H Sheikh Tamim bin Hamad Al Thani met yesterday at Sheikh Abdullah Bin Jassim Majlis at the Amiri Diwan with Minister of Foreign Affairs of the Republic of Iraq H E Fuad Mohammed Hussein, and the accompanying delegation.
Load more

Recommended publications
  • Cuba: One Year Into the Pandemic
    BULLETIN OF PAHO/WHO IN CUBA Vol. 25 No.1 JANUARY-MARCH 2021 CUBA: ONE YEAR INTO THE PANDEMIC 04 43 46 50 OUR NEWS: NOTEWORTHY: OVER A STORY A CUP OF TO TELL: Interview Benefits with Cuba's of a Cúrcumal onga COFFEE Dr. Ricardo Minister pdroject uring WITH… Pereda González: of Public Health, thep andemic Coordinator of Dr. José Angel Concepción the COVID-19 Clinical Portal Miranda Campa Experts Commission Huergo Pathways to Health is a bulletin prepared by the office of the Pan American Health Organization/World Health Organization EDITORIAL (PAHO/WHO) in Cuba. Its main aim is to share the most important aspects of the On March 11, 2020, the Director-General of the World Health Representation's technical cooperation with Organization (WHO) declared the novel coronavirus a pandemic, the country's Ministry of Public Health which at the time already affected 114 nations. Coincidentally, (MINSAP) and other institutions. that same day, the Pedro Kourí Tropical Medicine Institute (IPK) in Havana confirmed the first COVID-19 cases in Cuba. At the one-year anniversary of the pandemic in Cuba, this issue is dedicated to One year into the pandemic, more than 115 million cases and close to 2.6 million deaths have been reported from the disease systematically review key aspects of the worldwide. About half of both these cases and deaths have been national response over the last months. In registered in the Americas, with results differing according to how particular, it includes an interview with the well the response has been organized, how robust the healthcare Minister of Public Health, Dr.
    [Show full text]
  • Revision Rápida
    REVISION RÁPIDA EVALUACIÓN DE LAS CARACTERÍSTICAS DE ALMACENAMIENTO, TRANSPORTE Y DISTRIBUCIÓN DE LAS VACUNAS COVID-19 EN ESTUDIO, Y LAS CARACTERÍSTICAS CLÍNICAS DE LA POBLACIÓN CANDIDATA A VACUNACIÓN Noviembre de 2020 El Instituto de Evaluación Tecnológica en Salud – IETS, es una corporación sin ánimo de lucro, de participación mixta y de carácter privado, con patrimonio propio, creado según lo estipulado en la Ley 1438 de 2011. Su misión es contribuir al desarrollo de mejores políticas públicas y prácticas asistenciales en salud, mediante la producción de información basada en evidencia, a través de la evaluación de tecnologías en salud y guías de práctica clínica, con rigor técnico, independencia y participación. Sus miembros son el Ministerio de Salud y Protección Social – MinSalud, el Departamento Administrativo de Ciencia, Tecnología e Innovación – Colciencias, el Instituto Nacional de Vigilancia de Medicamentos y Alimentos – INVIMA, el Instituto Nacional de Salud – INS, la Asociación Colombiana de Facultades de Medicina – ASCOFAME y la Asociación Colombiana de Sociedades Científicas – ACSC. Autores Lucas López Quiceno. Médico y cirujano, Especialista en Epidemiología, Magister en Epidemiología, Magíster en economía de la salud (c). Instituto de Evaluación Tecnológica en Salud - IETS. Jhyld Carolaind Camacho Barbosa, Nutricionista y Dietista, Magister en Epidemiología. Instituto de Evaluación Tecnológica en Salud - IETS. Kelly Estrada-Orozco. Médica, Magister en Epidemiología Clínica, Magister en Neurociencia. Doctorado en Salud Pública (actual). Doctorado en Epidemiología Clínica (actual). Instituto de Evaluación Tecnológica en Salud - IETS. Revisores Cortes-Muñoz, Ani Julieth. Bacterióloga y laboratorista clínica. MSc. Epidemiología. Instituto de Evaluación Tecnológica en salud - IETS. Ospina-Lizarazo, Nathalie. Nutricionista Dietista. MSc. Epidemiología Clínica. Instituto de Evaluación Tecnológica en salud - IETS.
    [Show full text]
  • Iran Hopes to Defeat COVID with Home-Grown Crop of Vaccines
    Q&A Iran hopes to defeat COVID with home-grown crop of vaccines Iran is one of few Middle Eastern nations to transfer money is restricted, it is difficult with the capacity to develop vaccines. It to buy drugs and medicines. And we have has been doing so in earnest: more than the technology to produce vaccines, so why ten are in development, but little is known not use it? To ensure the safety of Iranians, it about them outside Iran. Nature speaks makes sense to develop a variety of vaccines to Kayhan Azadmanesh, head of the using different research and development virology division at the Pasteur Institute of strategies, as China has done. Iran in Tehran, about the nation’s vaccine landscape. Azadmanesh also advises the Why are Iranian researchers reluctant to Iranian government and is developing publicize their work internationally? vaccines through his spin-off company This could be another effect of the sanctions. Humimmune Biotech. Researchers in Iran might not want to draw too much attention to their work in case they How badly has the pandemic affected Iran? put potential partnerships in jeopardy or they Since January 2020, we’ve had five waves. run the risk of losing access to raw materials. We’re currently experiencing the highest Researchers are also extremely busy number of new cases reported so far, with during the pandemic. But some have started MAJID ASGARIPOUR/WANA VIA REUTERS MAJID ASGARIPOUR/WANA around 40,000 a day, and the most common to share results. In June, the researchers variant we detect is Delta.
    [Show full text]
  • COVID-19 Vaccines Update Supplement Week Of: 21Sth June, 2021
    CARPHA UPDATE FOR Incident Manager / SITUATION REPORT COVID-19 Vaccines Update Supplement Week of: 21sth June, 2021 I. Overview of Development and Regulatory Approvals: • 102 candidate vaccines are in clinical development: 18 in Phase 3 trials, and 5 in Phase 4 trials – Table 1; Figure in COVID-19 Vaccines and Therapeutics Regulatory Tracker (Phases tab). • 18 vaccines have received regulatory approvals in various countries, and 18 are at various stages of engagement with WHO for emergency use listing (EUL) including vaccines made in Cuba. • 8 vaccines have been approved by WHO for EUL to date: Pfizer-BioNTech’s vaccine: COMIRNATY®, AstraZeneca-SK Bio, AstraZeneca-SII (Covishield), Janssen-Cilag, AstraZeneca (Vaxzevria™), Moderna (mRNA-1273), Sinopharm-BIBP and Sinovac COVID-19 vaccine – CoronaVac: Table 4. • COVID-19 vaccine interim recommendations by the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) for reviewed vaccines may be found at: SAGE COVID-19 materials. • CARPHA’s COVID-19 vaccine regulatory tracker provides an overview of profiles and regulatory approvals for various candidate vaccines and therapeutics. This sheet includes information on the efficacy of the vaccines in light of current variants of concern, as per WHO updates. • CARPHA-CRS has recommended 7 COVID-19 vaccines to Member States to date – Table 4. The CRS has started its review of Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac. Table 1: Candidate Vaccines under Clinical evaluation, by type or platform. Platform Description Phase
    [Show full text]
  • The Covid–19 Pandemic and Haemglobin Isorders
    THE COVID–19 PANDEMIC AND HAEMGLOBIN ISORDERS UPDATE: 29 June 2021 Vaccinations “Immunization is a key component of primary health care and an indisputable human right. It is also one of the best health investments money can buy. Vaccines are thus critical to the prevention and control of infectious-disease outbreaks. They underpin global health security and will be a vital tool in the battle against antimicrobial resistance”. – WHO https://www.who.int/health- topics/vaccines-and- immunization “Since the beginning of the pandemic, WHO has taken steps to prevent an “infodemic”— defined by the organization as “an overabundance of information and the rapid spread of misleading or fabricated news, images, and videos.” WHO and the Wikimedia Foundation, the nonprofit organization that administers Wikipedia, have established a collaboration to expand the public’s access to the latest and most reliable information about COVID-19”. Information about the initiative is available at: https://www.who.int/news/item/22-10- 2020- the-world-health-organization-and-wikimedia-foundation-expand-access-to- trusted- information-aboutcovid-19-on-wikipedia TIF shares the concerns of false information and misleading overabundance of information. This often happens in the effort to enhance hope to a population that is suffering not only from the disease itself, but also from its economic future, since lockdown/isolation practices are stifling the market economies of every country around the world. Hope however, must be based on realistic expectations and information. For these reasons, TIF updates on new developments concerning vaccinations and new therapies are scanned for accuracy and are reviewed now more regularly.
    [Show full text]
  • COVID-19 Vaccine Coverage Soumya Swaminathan, WHO Chief Scientist
    COVID-19 vaccine coverage Soumya Swaminathan, WHO Chief Scientist 6 July 2021 DATA AS OF 5 JULY 8:00 AM CET 3,197M doses of COVID-19 vaccine have been administered1 in 215 countries, areas, territories & economies2 Total doses administered per 100 population Doses administered per 100 population 0-5 6-20 21-50 50+ Note: The designations employed and the presentation of these materials do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. 1 1. Source of data: WHO; Bloomberg; 2. Total of 220 countries, areas, territories & economies: 218 economies listed by World Bank + WHO Member states Cook Islands + Niue DATA AS OF 5 JULY 8:00 AM CET COVAX has now shipped 95.9M doses to 135 participants Incl. 69 LMIC/LICs; 40 participants started their first campaigns thanks to COVAX doses COVAX participants that received COVAX doses (incl. ones that started with others) Economies vaccinating only with bilateral doses or donations Economy not yet started vaccinating1 1. Burundi, Eritrea, United Republic of Tanzania, Haiti, Democratic People's Republic of Korea Note: The designations employed and the presentation of these materials do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Status of COVID-19 Vaccines Within WHO EUL/PQ Evaluation Process
    Vaccines Guidance Document 07 April 2021 Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process Manufacturer Name of Vaccine NRA of Record Platform EOI Pre-submission Dossier accepted for Status of assessment** Anticipated decision accepted meeting held review* date*** 1. BNT162b2/COMIRNATY EMA Nucleoside modified mNRA Finalized 31/12/20 Tozinameran (INN) 2. AZD1222 Core – EMA Non- Recombinant ChAdOx1 adenoviral Accepted core data of Core data – now as 1st wk April 2021 COVAX vector encoding the Spike protein AZ – non-Covax donation for COVAX. antigen of the SARS-CoV-2. Data for Covax sites Awaited April 2021 onwards EU Nodes expected in April 2021 onwards 3. AZD1222 MFDS KOREA Recombinant ChAdOx1 adenoviral Finalized 15 Feb 2021 SK BIO vector encoding the Spike protein antigen of the SARS-CoV-2. 4. Serum Institute of India Covishield (ChAdOx1_nCoV- DCGI Recombinant ChAdOx1 adenoviral Finalized 15 Feb 2021 19) vector encoding the Spike protein antigen of the SARS-CoV-2. 5. Ad26.COV2.S EMA Recombinant, replication- Core data (US +NL sites) Finalized 12 March 2021 incompetent adenovirus type 26 (Ad26) vectored vaccine encoding Additional sites awaited Awaited To be fixed after data the (SARS-CoV-2) Spike (S) protein submission 6. 1 SARS-CoV-2 Vaccine (Vero NMPA Inactivated, produced in Vero cells In progress End April 2021 Sinopharm / BIBP Cell), Inactivated (lnCoV) 7. SARS-CoV-2 Vaccine (Vero NMPA Inactivated, produced in Vero cells In progress End April 2021 Cell), Inactivated 8. mRNA-1273 EMA mNRA-based vaccine In progress using the Mid. April 2021 encapsulated in lipid nanoparticle abridged procedure (LNP) (EMA).
    [Show full text]
  • “Estamos Trabajando Para La Nueva Normalidad”
    K Y M C EN FALLIDO ROBO Distribución en La Plata, Berisso y Ensenada. Precio de tapa: $50 Incendiaron un club a Entrega bajo puerta: $50 metros del destacamento policial de Arturo Seguí Año XXVII • Nº 8866 -PÁG. TRAMA URBANA Edición de 32 páginas En la noticia La Plata, lunes 28 de junio de 2021 15 Boom exportador bonaerense En lo que refiere a ventas al exterior, “Estamos trabajando para la Provincia tuvo este año su cuatrimestre récord en casi una década. El fenómeno es impulsado por el crecimiento de las Diario laHoy dialogó nueva con el presidente de la normalidad”Universidad Nacional de La Plata, Fernando Tauber, quien manufacturas, pero también por otras producciones que atraen a se refirió a la importante labor que desarrollan desde las diferentes áreas para enfrentar la pandemia países como Indonesia e Irán -PÁG. 10 -PÁG. 6 Descubren dos nuevos ejemplares de yaguareté -PÁG. 13 Rápidos y furiosos 9 lidera la taquilla -PÁG. 12 ESPECTÁCULOS FÚTBOL “AMERICANO” Juega la Selección y diario Hoy entrevistó a los campeones Con el fin de agasajar al personal sanitario y agradecerle por su esfuerzo en la pandemia, vecinos de Ringuelet El conjunto de Scaloni enfrentará desde desdeAmor hace tres meses regalan facturasy ensolidaridad las guardias de los nosocomios y en las postas de vacunación las 21 a Bolivia buscando asegurarse la cima del Grupo A. Este multimedio -PÁG. 9 conversó en Brasilia con los integrantes del equipo de fútbol americano que ganaron allí el segundo título consecutivo Los lugares ideales para el cicloturismo en Argentina -PÁG. 15 -PÁGS.
    [Show full text]
  • Olga Lidia Jacobo-Casanueva MS Director, Center for State Control of Medicines and Medical Devices (CECMED)
    Cuba's Women of Science Cuba’s National Regulatory Authority & COVID-19: Olga Lidia Jacobo-Casanueva MS Director, Center for State Control of Medicines and Medical Devices (CECMED) Tania L. Aguilar-Guerra MD MS, Esther M. Fajardo-Díaz MS, Conner Gorry MA As of this writing, more than 4.6 million Cubans (over 40% of the population on the island), had received at least their E. Añé fi rst dose of Soberana 02 or Abdala, two of fi ve vaccine candidates for SARS-CoV-2 developed and produced on the island. Late-phase clinical trial data revealed that Abdala is 92.28% effective after the full, three-dose cycle and Soberana 02 is 91.2% effective after two doses, when followed by a booster of Soberana Plus.[1] Cuban health authorities have committed to vaccinating the entire population, including children aged 3–18 years old, using these vaccines by the end of 2021. The fi rst pre-clinical, peer-reviewed data are available,[2] with clinical trial results already submitted to various international journals. Building on decades of biotechnology know-how developing, producing and administering 11 preventive vaccines for childhood diseases—used in the nation’s universal health system and also marketed elsewhere—Cuba is the fi rst, and to date only, country in Latin America and the Caribbean to develop its own vaccine candidates for COVID-19 (Soberana 01; Soberana 02; Soberana Plus; Abdala and Mambisa; see Box on following page). In a strategy designed to ensure comprehensive and importantly, independent solutions to the global health crisis, research institutes and manufacturing hands-on experience in nearly every facet of regulation.
    [Show full text]
  • Coronavirus: Quello Che C'è Da Sapere – 19 Luglio 2021
    Coronavirus: quello che c’è da sapere – 19 luglio 2021 Sommario Quando è iniziata l’epidemia? ......................................2 Che cosa sono i test sierologici? a cosa servono? ................................26 Quando è arrivata in Italia? ..........................................2 Chi viene colpito dalla malattia Covid-19? ............................................26 A cosa è dovuta l’infezione? .........................................2 Quanto è letale il virus? Quali sono i fattori di rischio? .........................26 Quanto è diffusa l’epidemia? ....................................................................2 Quali sono le conseguenze a medio e lungo termine del Covid-19? .....31 Che cosa sono i coronavirus? ...................................................................2 Qual è l’origine del virus? .........................................................................4 Il virus può diventare endemico?............................................................32 Il virus può mutare? ..................................................................................4 Esiste un vaccino? ...................................................................................33 Come si trasmette l’infezione? ...............................................................10 Quali sono le terapie disponibili?............................................................48 I bambini sono più soggetti all’infezione? .............................................14 Quali sono i rischi sanitari legati all’epidemia? .....................................60
    [Show full text]
  • Current Scenario of Sars-Coronavirus 2: Epidemiology; Post-Covid-19 and Global Impacts
    CURRENT SCENARIO OF SARS-CORONAVIRUS 2: EPIDEMIOLOGY; POST-COVID-19 AND GLOBAL IMPACTS Vishnu Priya Sampatha*, Prasannaraj Govindarajb, Ramasamy Subbiah c, Makesh Mohand Address(es): a State-Key Laboratory for Mechanical Behavior of Materials, School of Material Science & Engineering, Xi'an Jiaotong University, Xi'an 710049, China. b Neurochemistry Laboratory, Department of Neurological Sciences, Christian Medical College and Hospital, Vellore 632004, Tamil Nadu, India. c Cardiac Hypertrophy Laboratory, Department of Molecular Biology, School of Biological Sciences, Madurai Kamaraj University, Madurai 625021, Tamil Nadu, India. d Department of Physics, National Institute of Technology, Karnataka (NITK) Surathkal 575025, Karnataka, India. *Corresponding author: [email protected] https://doi.org/10.15414/jmbfs.4066 ARTICLE INFO ABSTRACT Received 11. 12. 2020 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a highly contagious strain of coronavirus that causes Coronavirus Disease 2019 (COVID-19) infection, which has distressed the world's health and wealth. This Global Pandemic outbreak has affected Revised 17. 6. 2021 public health enormously at various customs. The investigation of SARS-CoV-2 is still at infancy; however, based on the available Accepted 29. 6. 2021 reports, this review gives an overview of the epidemiology, genomic landscape, diversity of SARS-CoV-2, viral genome pathogenic Published xx.xx.201x interactions, associating factors for COVID-19 infections, post-COVID-19, disease manifestations with their comorbidities, the major obstacles and the preventive measures along with current vaccine strategies of SARS-CoV-2. This review also summarizes all the Regular article relevant evidence of COVID-19 illness, which can provide valuable information on the SARS-CoV-2 genome and its mode of action strategies, thus delivering additional knowledge about COVID-19.
    [Show full text]
  • INDIA the Government Must Revitalise Public Sector Units to Meet COVID-19 Vaccine Requirements
    16-30 APRIL, 2021 DownToEarthSCIENCEFORTNIGHTLY AND ENVIRONMENTON POLITICS OF FORTNIGHTLY DEVELOPMENT, ENVIRONMENT AND HEALTH Subscriber copy, not for resale `60.00 AFRICA Inequitable global distribution of vaccines will only prolong the pandemic for every country AT RISK AT INDIA The government must revitalise public sector units to meet COVID-19 vaccine requirements 01Cover.indd 1 12/04/21 9:41 AM Advertisement 02JSES- Magazine Advt- Feb 2021- PDF.indd 2 09/04/21 12:32 PM SUNITA NARAIN \EDIT Zero-zero, net zero E HAVE seen furious activity on climate change in the first weeks of April in Delhi. No, I am not talking about action to fight climate change. I am talking about words and more words—much has been W written about the position that India must take or not take when it comes to declaring a net-zero goal. Much has been discussed in closed-door meetings on the same. John Kerry, the US climate envoy, was in town in the lead up to President Joe Biden’s climate leaders summit on April 22-23. He wanted to cajole and push us to act—say something big when the leaders meet. The good news is that climate change is back on the agenda. The bad news is that we are discussing the wrong things; we are in danger of once again losing the opportunity to drive home the need for ambition and equity in climate change action. Just consider the narrative in Delhi. It was not about the need to take stock of what has been done or not done to meet the Paris commitments—the voluntary targets countries have taken to reduce greenhouse gas emissions in this decade; it was not about how minuscule, completely off track and inequitable the Paris targets are.
    [Show full text]